GLP-1 Weight Loss Medications Safety and Effectiveness
Evaluating GLP-1 Agonists in Contemporary Obesity Management In the evolving landscape of obesity treatment, glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a transformative class of weight loss medications. Leveraging their incretin-mimetic properties, these agents modulate appetite and glucose metabolism, presenting a paradigm shift from traditional pharmacotherapies. However, the dual imperative of safety and effectiveness … Read more